Copyright: ©Author(s) 2026.
World J Nephrol. Sep 25, 2026; 15(3): 120037
Published online Sep 25, 2026. doi: 10.5527/wjn.120037
Published online Sep 25, 2026. doi: 10.5527/wjn.120037
Table 3 Correlation among tumour necrosis factor-alpha and high-sensitivity C-reactive protein and participants’ age, blood pressure and laboratory parameters of the studied groups
| TNF-α (ng/L) after 6 months | hs-CRP (mg/L) after 6 months | |||||||
| r value1 (group 1) | P value (group 1) | r value1 (group 2) | P value (group 2) | r value1 (group 1) | P value (group 1) | r value1 (group 2) | P value (group 2) | |
| Age | 0.100 | 0.667 | -0.052 | 0.823 | 0.238 | 0.298 | 0.128 | 0.579 |
| SBP after 6 months | 0.072 | 0.756 | 0.304 | 0.180 | 0.237 | 0.302 | 0.049 | 0.832 |
| DBP after 6 months | 0.078 | 0.738 | 0.318 | 0.160 | 0.082 | 0.723 | 0.145 | 0.530 |
| MAP after 6 months | 0.112 | 0.629 | 0.020 | 0.933 | 0.094 | 0.685 | 0.073 | 0.754 |
| Laboratory parameters | ||||||||
| Hb (gm/dL) | -0.040 | 0.864 | 0.101 | 0.663 | 0.327 | 0.148 | -0.102 | 0.659 |
| WBCs (× 103/μl) | 0.487 | 0.025a | 0.083 | 0.720 | -0.113 | 0.627 | 0.172 | 0.457 |
| Platelet (× 103/μl) | -0.127 | 0.585 | -0.063 | 0.786 | 0.043 | 0.852 | 0.242 | 0.291 |
| BUN (mg/dL) | 0.262 | 0.250 | 0.301 | 0.186 | 0.364 | 0.105 | -0.206 | 0.371 |
| Cr (mg/dL) | 0.477 | 0.029a | 0.579 | 0.006a | 0.143 | 0.535 | -0.185 | 0.423 |
| Na (meq/L) | 0.115 | 0.619 | -0.071 | 0.761 | 0.102 | 0.658 | 0.222 | 0.334 |
| K (meq/L) | -0.279 | 0.222 | 0.193 | 0.402 | -0.397 | 0.075 | 0.117 | 0.613 |
| Ca (mg/dL) | -0.269 | 0.238 | -0.100 | 0.666 | -0.365 | 0.104 | 0.454 | 0.039a |
| PO4 (mg/dL) | 0.126 | 0.586 | 0.041 | 0.861 | 0.269 | 0.239 | 0.005 | 0.983 |
| Intact PTH (pg/mL) | 0.104 | 0.655 | 0.179 | 0.439 | -0.326 | 0.150 | -0.184 | 0.424 |
| hs-CRP (mg/L) after 6 months | 0.223 | 0.331 | 0.143 | 0.537 | - | - | - | - |
| UPCR (mg/g) after 6 months | 0.110 | 0.634 | 0.084 | 0.717 | 0.236 | 0.304 | -0.120 | 0.604 |
| eGFR (mL/minute/1.73 m2) after 6 months | -0.134 | 0.562 | -0.440 | 0.046a | -0.057 | 0.805 | -0.062 | 0.789 |
- Citation: Abd El Mobdy AH, Hebah HA, Ezzat MA, Eid Mohamed BA, Ahmed FA. Effect of pentoxifylline on inflammatory markers in non-diabetic chronic kidney disease patients: A prospective, interventional, open label. World J Nephrol 2026; 15(3): 120037
- URL: https://www.wjgnet.com/2220-6124/full/v15/i3/120037.htm
- DOI: https://dx.doi.org/10.5527/wjn.120037